Skip to main content
Log in

Oxycodone/paracetamol: a guide to its use in the treatment of moderate to severe musculoskeletal pain

  • Drug and Profile Reports
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Table I

References

  1. Barkin Rl. Acetaminophen, aspirin, or ibuprofen in combination analgesic products. Am J Therapeut 2001; 8(6): 433–42

    Article  CAS  Google Scholar 

  2. Auret K, Schug SA. Underutilisation of opioids in elderly patients with chronic pain: approaches to correcting the problem. Drugs Aging 2005; 22(8): 641–54

    Article  PubMed  CAS  Google Scholar 

  3. Nikolaus T, Zeyfang A. Pharmacological treatments for persistent non-malignant pain in older persons. Drugs Aging 2004; 21(1): 19–41

    Article  PubMed  CAS  Google Scholar 

  4. Devulder J, Richarz U, Nataraja SH. Impact of long-term use of opioids on quality of life in patient with chronic, non-malignant pain. Curr Med Res Opin 2005; 21(10): 1555–69

    Article  PubMed  CAS  Google Scholar 

  5. Bannwarth B. Risk-benefit assessment of opioids in chronic non-cancer pain. Drug Saf 1999 Oct; 21(4): 283–96

    Article  PubMed  CAS  Google Scholar 

  6. World Health Organization. Cancer pain relief with a guide to opioid availability. 2nd ed. Geneva: WHO, 1996

    Google Scholar 

  7. Depalgos (oxycodone plus paracetamol): summary of product characteristics [in Italian]. L. Molteni s& C. dei Fratelli Alitti Società di Esercizio S.p.A.; Florence, Italy, 2006

  8. Institute for Clinical Systems Improvement. Health care guideline: assessment and management of chronic pain [online]. Available from URL: http://www.icsi.org [Accessed 2008 Aug 16]

  9. Institute for Clinical Systems Improvement. Health care guideline: assessment and management of acute pain [online]. Available from URL: http://www.icsi.org [Accessed 2008 Aug 16]

  10. Sweetman S, editor. Martindale: the complete drug reference. 35th ed. London: Pharmaceutical Press, 2007

    Google Scholar 

  11. WoltersKluwer Health Inc. Facts & comparisons 4.0 [online]. Available from URL: http://online.factsandcomparisons.com [Accessed 2008 Aug 15]

  12. Riley J, Eisenberg E, Müller-Schefe G, et al. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 2008; 24(1): 175–92

    Article  PubMed  CAS  Google Scholar 

  13. Kalso E, Allan L, Dellemijn PL, et al. Recommendations for using opioids in chronic non-cancer pain. Eur J Pain 2003; 7(5): 381–6

    Article  PubMed  CAS  Google Scholar 

  14. Gammaitoni AR, Galer BS, Lacouture P, et al. Effectiveness and safety of new oxycodone/acetaminophen formulations with reduced acetaminophen for the treatment of low back pain. Pain Med 2003 Mar; 4(1): 20–30

    Article  Google Scholar 

  15. Nicholson B. Responsible prescribing of opioids for the management of chronic pain. Drugs 2003; 63(1): 17–31

    Article  PubMed  Google Scholar 

  16. Jamison RN, Schein JR, Vallow S, et al. Neuropsychological effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage 2003 Oct; 26(4): 913–21

    Article  PubMed  Google Scholar 

  17. Verster JC, Veldhuijzen DS, Volkerts ER. Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 2006 Jun; 22(5): 499–504

    Article  PubMed  Google Scholar 

  18. Schug SA, Zech D, Grond S. Adverse effects of systemic opioid analgesics. Drug Saf 1992; 7(3): 200–13

    Article  PubMed  CAS  Google Scholar 

  19. Savage SR. Assessment for addiction in pain-treatment settings. Clin J Pain 2002; 18(4 Suppl.): S28–38

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oxycodone/paracetamol: a guide to its use in the treatment of moderate to severe musculoskeletal pain. Drugs Ther. Perspect 24, 5–8 (2008). https://doi.org/10.2165/00042310-200824100-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824100-00002

Navigation